Kachra Z, Yang C R, Posner B I
Polypeptide Hormone Laboratory, Royal Victoria Hospital, Montreal, Quebec, Canada.
Endocrinology. 1994 Feb;134(2):702-8. doi: 10.1210/endo.134.2.7507834.
In previous studies it was shown that bovine GH (bGH) and glucagon, when individually added to primary rat hepatocyte cultures, modestly stimulated IGF-I mRNA levels 1.8- to 2.5-fold, but when combined, synergized to stimulate IGF-I mRNA levels by 10- to 12-fold. In the present study we have explored further the mechanism of this effect in primary rat hepatocyte cultures. Like glucagon, the addition of 3-isobutyl-1-methylxanthine (100 microM) or (Bu)2cAMP (150 microM) augmented IGF-I mRNA levels 1.8- to 2.0-fold, but when combined with bGH (50 ng/ml), they augmented levels up to 12-fold. The half-life of IGF-I mRNA, determined by incubating hepatocytes with actinomycin-D was 12 h. Although bGH did not affect the decay rate, glucagon (100 ng/ml) or (Bu)2cAMP (100 microM) reduced the rate of loss by about 70%. 4 beta-Phorbol 12 beta-myristate 13 alpha-acetate minimally stimulated IGF-I mRNA levels 1.2- to 1.4-fold, but displayed no synergism when added with bGH, glucagon, or (Bu)2cAMP. The stimulatory effect of bGH plus glucagon was inhibited 80% after preincubation with 4 beta-phorbol 12 beta-myristate 13 alpha-acetate (10 microM) for 24 h. The addition of staurosporine, sphingosine, or H-7 [1-(5-isoquinolinyl sulfonyl)2-methyl piperazine] inhibited the stimulatory effect of bGH plus glucagon on hepatocyte IGF-I mRNA by 80%, 90%, and 85%, respectively. Preincubation with cycloheximide (10 micrograms/ml) blocked the synergistic effect of bGH plus either glucagon or (Bu)2cAMP by 65-80%. The effect of glucagon, mediated via the activation of adenylate cyclase, involves in part the posttranscriptional stabilization of IGF-I mRNA levels. The effect of GH, mediated in part by the activation of protein kinase-C, appears to be at the level of transcription. The synergistic augmentation of hepatocyte IGF-I mRNA levels by GH and glucagon involves the activation of PKA and PKC, but also appears to require the synthesis of one or more protein(s).
在先前的研究中发现,将牛生长激素(bGH)和胰高血糖素单独添加到原代大鼠肝细胞培养物中时,可适度刺激IGF-I mRNA水平升高1.8至2.5倍,但两者联合使用时,则可协同刺激IGF-I mRNA水平升高10至12倍。在本研究中,我们进一步探讨了原代大鼠肝细胞培养物中这种效应的机制。与胰高血糖素一样,添加3-异丁基-1-甲基黄嘌呤(100 microM)或双丁酰环磷腺苷(150 microM)可使IGF-I mRNA水平升高1.8至2.0倍,但与bGH(50 ng/ml)联合使用时,可使水平升高至12倍。通过用放线菌素-D孵育肝细胞测定的IGF-I mRNA半衰期为12小时。虽然bGH不影响衰减率,但胰高血糖素(100 ng/ml)或双丁酰环磷腺苷(100 microM)可使损失率降低约70%。4β-佛波醇12β-肉豆蔻酸酯13α-乙酸酯对IGF-I mRNA水平的刺激作用最小,升高1.2至1.4倍,但与bGH、胰高血糖素或双丁酰环磷腺苷联合添加时无协同作用。用4β-佛波醇12β-肉豆蔻酸酯13α-乙酸酯(10 microM)预孵育24小时后,bGH加胰高血糖素的刺激作用被抑制80%。添加星形孢菌素、鞘氨醇或H-7 [1-(5-异喹啉磺酰基)2-甲基哌嗪]分别使bGH加胰高血糖素对肝细胞IGF-I mRNA的刺激作用抑制80%、90%和85%。用环己酰亚胺(10微克/毫升)预孵育可使bGH加胰高血糖素或双丁酰环磷腺苷的协同作用阻断65 - 80%。胰高血糖素通过激活腺苷酸环化酶介导的效应部分涉及IGF-I mRNA水平的转录后稳定。生长激素部分通过激活蛋白激酶-C介导的效应似乎在转录水平。生长激素和胰高血糖素对肝细胞IGF-I mRNA水平的协同增强涉及PKA和PKC的激活,但似乎也需要合成一种或多种蛋白质。